Lunit Insight MMG & DBT
de Volpara Health, Inc.
Empower healthcare providers with AI-driven cancer prevention solutions.
Lunit Insight MMG & DBT is an advanced AI-driven diagnostic support tool designed to empower healthcare providers in the fight against breast cancer. Utilizing Lunit’s cutting-edge deep learning technology, this solution accurately detects lesions suspicious of breast cancer through heatmaps and abnormality scores, providing critical insights for radiologists during primary interpretation.
Ideal for radiologists and healthcare institutions, Lunit Insight MMG & DBT enhances diagnostic accuracy, particularly in dense breast cases, and aids in the early detection of invasive cancers. With its proven ability to increase breast cancer detection rates by up to 18% and reduce false positives by up to 14%, it addresses the pressing need for reliable and efficient diagnostic tools in mammography.
Backed by rigorous training on over 200,000 high-quality cases and validated to perform at a standalone accuracy of 96% in ROC AUC, this solution significantly improves radiologists' interpretive capabilities. Approved by global regulatory bodies like FDA, CE, and Korea MFDS, Lunit Insight MMG & DBT is a trusted partner in advancing breast cancer prevention and diagnostics.